openPR Logo
Press release

Enzyme Linked Immunosorbent Assay (ELISA) Market Projected to Grow Steadily During 2018-2026 With Top Players Bio-Rad Laboratories Inc, Enzo Life Sciences Inc, Thermo Fisher Scientific Inc, Biomerieux S.A., Alpco, BioLegand Inc, Zeus Scientific Inc

02-19-2019 01:23 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Clinical Diagnostic

Enzyme Linked Immunosorbent Assay

Enzyme Linked Immunosorbent Assay

Market players are engaged in development of innovative products to maintain leading position in global Enzyme Linked Immunosorbent Assay (ELISA) Market

The key players are developing novel, innovative, and smart products to maintain leading position in the Enzyme Linked Immunosorbent Assay (ELISA) Market. For instance, in January 2017 Illumina, Inc. and Bio?Rad Laboratories, Inc. introduced the Illumina Bio-Rad Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic responses. Moreover, in 2015, Enzo Life Sciences introduced new VEGF ELISA Kit, an ultra-sensitive assay as competitive detection method for measuring VEGF in serum, plasma, and cell culture supernatants that measures as little as 4 pg /ml of VEGF and provide quantitative results.

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/1505

Key players operating the global Enzyme Linked Immunosorbent Assay (ELISA) Market include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Market Dynamics

The Enzyme Linked Immunosorbent Assay (ELISA) Market is expanding owing to the increasing incidence of chronic diseases mainly in case of infectious diseases, vector borne diseases and cancer. According to the National Cancer Institute, cancer has a major impact on the population of U.S. and across the world. The NCI reports approximately 1,685,210 new cases of cancer were diagnosed in 2016. Also, reports demand for efficient detection tests that can be sufficed with the help of ELISA test kits. Moreover, increasing demand for cost-effective diagnostic tool is one of the factor aiding the growth of ELISA market, especially in the low and middle income economies.

Factors such as increasing incidence of infectious diseases and cancer coupled with increasing demand for cost-effective diagnostic tools are expected to drive growth of the Enzyme Linked Immunosorbent Assay (ELISA) market. According to the Centers of Disease Control & Prevention (CDC), 2015, the number of visits to physician offices for infectious and parasitic diseases in the U.S. was 16.8 million. Furthermore, vector borne diseases comprise a major percentage of infectious diseases and affects a wide population. According to the World Health Organization (WHO), 2017, annually vector borne diseases accounts for over 17% of all infectious diseases causing over 700,000 deaths worldwide. Dengue is most commonly occurring vector borne disease with around 96 million new cases diagnosed annually. Moreover, advancements in the technology of ELISA are also fueling the market growth.

In August 2017, researchers at University of Illinois, Urbana Campaign, developed a portable spectral analyzer based on ELISA assay that enables a smartphone to perform lab grade medical diagnostic tests, which usually requires expensive instruments. This test includes detection and measurement of variety of proteins and antibodies in blood, urine, and saliva samples that is commonly used for wide range of clinical diagnostic tests. Apart from the conventional medical applications such as disease diagnosis and transplantation, ELISA can also be used in the field of toxicology for determination of certain classes of drugs that is expected to aid the market growth in near future.

In terms of region, North America dominated the global Enzyme Linked Immunosorbent Assay (ELISA) Market. This is attributed to development of innovative products by manufacturers in the region. For instance, in January 2018, Eagle Biosciences, Inc. introduced a novel intact FGF23 ELISA kit assay, which is a 96 well Sandwich ELISA assay. It measures the full length active form of Human Intact FGF23 used for the detection of Mineral Bone Disorder, Chronic Kidney Disease, Tumor induced Osteomalacia, and hyperphosphatemia. Moreover, various private and public sectors carrying out research and development in Immunoassay-based clinical diagnostics are commercializing their research inventions by collaborating with existing market players to introduce new products in the market.

Else, Place an Enquiry To Talk With Our Analyst : https://www.coherentmarketinsights.com/insight/talk-to-analyst/1505

Asia Pacific is projected to be the fastest growing region in ELISA market, owing to geographical expansion of regional players along with introduction of novel enzyme-based test kits at affordable prices. For instance, in January 2017, Fujirebio, a Japan-based IVD diagnostic testing company introduced Lumipulse G β-Amyloid 1-42 ELISA assay in Europe that facilitates quantitative measurement of β-amyloid1-42 in human cerebrospinal fluid within of 30 minutes.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enzyme Linked Immunosorbent Assay (ELISA) Market Projected to Grow Steadily During 2018-2026 With Top Players Bio-Rad Laboratories Inc, Enzo Life Sciences Inc, Thermo Fisher Scientific Inc, Biomerieux S.A., Alpco, BioLegand Inc, Zeus Scientific Inc here

News-ID: 1599931 • Views: 491

More Releases from Coherent Market Insights - Clinical Diagnostic

Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives
Western Blotting Market: Future and Technological Advancement 2026 By Top Player …
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives
Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top …
Cannabis testing is done for various purpose such as finding concentration of active ingredient (cannabinoids, terpene), which determines the medical potency of the cannabis. It is also tested for determining various other ingredient in given sample. For instance, to determine the pesticide residue content in the given sample that undermines the purity and efficacy. Cannabis testing also involves determination of contaminants such as fungi and bacteria (mycotoxins), which could causes
Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Player …
Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis

All 5 Releases


More Releases for ELISA

ELISA Technologies Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the ELISA Technologies industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The ELISA Technologies market survey report has been prepared by conducting market research in a systematic manner. Moreover, the ELISA Technologies report includes a professional in-depth study
Global ELISA Analyzers Market Research Report
This report studies the global ELISA Analyzers market status and forecast, categorizes the global ELISA Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Thermo Fisher PerkinElmer Tecan BioTek EUROIMMUN DiaSorin BIO-RAD Molecular Devices Dynex Technologies BMG Labtech KHB Promega Trinity
Global ELISA Processors Market Research Report 2018
In this report, the global ELISA Processors market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ELISA Processors in these regions, from 2013 to 2025 (forecast), covering
ELISA Analyzer Market trend, outlook 2025
Enzyme Linked Immunosorbent Assay (ELISA) is a biochemical assay, which use antibodies and an enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in sample. Enzyme-linked immunosorbent assay is used as diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample. ELISA analyzer can be
ELISA Reagents Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –" ELISA Reagents Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-elisa-reagents-market-research-report-2017-1541198 In this report, the global ELISA Reagents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key
Global ELISA Reagents Sales Market Report 2017
The Global ELISA Reagents Sales Market Report 2017 is a professional and in-depth study on the current state of the ELISA Reagents industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The ELISA Reagents market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost